Skip to main content

Improving Access to Overdose Treatment

 
Catalog of Federal Domestic Assistance Number: 93.243
Sponsors
Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Deadlines
Jun 4, 2018
Contact

For programmatic or technical questions:
Tonia F. Gray, MPH
240.276.2492
tonia.gray@samhsa.hhs.gov

Kim Nesbitt, MA
240.276.1742
GHR0@cdc.gov

For grants management or budget questions:
Eileen Bermudez
240.276.1412
FOACSAP@samhsa.hhs.gov

Purpose

The Improving Access to Overdose Treatment program provides grants to expand access to Food and Drug Administration approved drugs and/or devices for emergency treatment of known or suspected opioid overdose through planning, training, and the development of protocols.

Required activities include:

  • Establish a program for emergency treatment of known or suspected opioid overdose
  • Train and provide resources for healthcare providers and pharmacists on the prescribing of drugs or devices for emergency treatment of known or suspected opioid overdose
  • Establish protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment, and appropriate counseling and behavioral therapies
  • Develop a plan for sustaining the program after Federal support for the program has ended
  • Use SAMHSA’s Opioid Overdose Prevention Toolkit as a guide to develop and implement a comprehensive prevention program to reduce the number of prescription drug/opioid overdose-related deaths and adverse events among cases of known or suspected opioid overdose
  • Address overdose by patients on prescribed opioids

Up to 20% of the grant may be used for:

  • Purchase of approved drugs or devices for distribution under the program
  • Offset the co-payments and other cost sharing associated with approved drugs or devices for emergency treatment of known or suspected opioid overdose
Eligibility

Eligible applicants are:

  • Federally Qualified Health Centers
  • Opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations
  • Practitioners who dispense narcotic drugs pursuant to section 303(g) of the Controlled Substances Act
Geographic coverage
Nationwide
Amount of funding

Estimated award amount: $200,000 per year
Project period: Up to 5 years
Estimated number of awards: 5
Estimated total program funding: $940,000

Application process

Links to the full announcement and online application process are available through grants.gov.

Tagged as
Federally Qualified Health Centers · Illicit drug use · Pharmacy and prescription drugs · Prescription drug abuse



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.